Enrollment and Consent Form

Fields marked with a * are required.

SIMLANDITM (adalimumab), biosimilar to HUMIRA®
I. PATIENT SECTION
II. ENROLLING HEALTHCARE PROFESSIONAL INFORMATION
III. CONSENT
If you have questions regarding the program, please contact the JAMP Care Patient Support Program: 1-855-310-5102